DDW: Digestive Disease Week

In an abstract presented at Digestive Disease Week 2024, researchers analyzed Clostridioides difficile episodes and identified the risk factors and potential medications that caused them.

In an abstract presented at Digestive Disease Week 2024, researchers analyzed the prevalence of obesity in patients with and without celiac disease.

Participants with the hungry gut phenotype, identified by the MyPhenome Hungry Gut test, were able to lose double the amount of weight on semaglutide compared to those without.

Study findings can raise awareness for both patients and health care providers about vitamin D deficiency as a potential contributor to bleeding risk, as well as lead to more personalized treatment approaches for patients on blood thinners.

Research presented at DDW 2024 found there was no significant association between immune response and hepatitis B vaccine types in patients with Hepatitis C.

Research presented at Digestive Disease Week suggests that including omega-3 rich foods, or omega-3 supplements, into a healthy diet could offer additional protection against colorectal cancer alongside regular screening.

A poster presented at Digestive Disease Week showed that patients with MASLD taking semaglutide achieved significant weight loss while preserving skeletal muscle indices.